Reprogramming parasitic signatures into anticancer peptide candidates: in silico discovery of Leishmania major-derived peptides
{{output}}
This study aims to computationally identify and prioritize anticancer peptide (ACP) candidate sequences derived from the Leishmania major proteins KMP11 and GP63 using an integrated bioinformatics framework that incorporates peptide design, safety assessment, ... ...
